电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant ACADVL 抗体

The 兔 单克隆 anti-ACADVL antibody (Clone 32A31) (ABIN7879891) specifically detects ACADVL in WB, IHC 和 IP. The antibody is reactive with 人 samples.
产品编号 ABIN7879891
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant ACADVL 抗体 (ABIN7879891)

抗原

See all ACADVL 抗体
ACADVL (Acyl-CoA Dehydrogenase, Very Long Chain (ACADVL))

抗体类型

Recombinant Antibody

适用

  • 57
  • 8
  • 8
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1

宿主

  • 53
  • 2
  • 2

克隆类型

  • 45
  • 12
单克隆

标记

  • 24
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ACADVL antibody is un-conjugated

应用范围

  • 32
  • 17
  • 15
  • 15
  • 14
  • 13
  • 13
  • 6
  • 6
  • 3
  • 3
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP)

克隆位点

32A31
  • 原理

    ACADVL Antibody / VLCAD

    纯化方法

    Affinity-chromatography

    免疫原

    A synthesized peptide derived from human ACADVL/VLCAD was used as the immunogen for the ACADVL antibody.

    亚型

    IgG
  • 应用备注

    Optimal dilution of the ACADVL antibody should be determined by the researcher.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    Store the ACADVL antibody at -20oC.
  • 抗原

    ACADVL (Acyl-CoA Dehydrogenase, Very Long Chain (ACADVL))

    别名

    ACADVL

    背景

    ACADVL antibody is designed to detect very long-chain specific acyl-CoA dehydrogenase (VLCAD), a mitochondrial enzyme encoded by the ACADVL gene. VLCAD is a key enzyme in the mitochondrial fatty acid beta-oxidation pathway, responsible for catalyzing the initial dehydrogenation of very long-chain acyl-CoA substrates. This activity is essential for energy production, especially during fasting or prolonged exercise when fatty acids serve as a major energy source. VLCAD is located on the inner mitochondrial membrane and plays a central role in maintaining metabolic balance and ATP generation.

    ACADVL antibody is an important tool in metabolic and mitochondrial research. Deficiency of VLCAD due to mutations in the ACADVL gene leads to very long-chain acyl-CoA dehydrogenase deficiency, an inherited metabolic disorder characterized by hypoglycemia, cardiomyopathy, and muscle weakness. By detecting VLCAD expression and localization, researchers can investigate the molecular basis of fatty acid oxidation disorders and explore therapeutic approaches.

    Applications of ACADVL antibody include western blotting, immunohistochemistry, immunofluorescence, and flow cytometry. In western blot assays, the antibody specifically detects VLCAD protein, enabling comparison of expression across tissues and experimental conditions. Immunohistochemistry provides mitochondrial localization patterns in tissue sections, while immunofluorescence highlights subcellular distribution in cultured cells. These applications make the antibody useful for both clinical research and basic studies of metabolism.

    In addition to its clinical relevance, VLCAD has been linked to metabolic regulation in cancer and cardiovascular disease. Altered fatty acid oxidation is a hallmark of many cancers, and modulation of VLCAD activity influences tumor growth and metabolic reprogramming. In cardiology, VLCAD function is crucial for sustaining energy production in heart tissue, particularly under stress. Using ACADVL antibody, researchers can study how VLCAD expression correlates with disease progression and therapeutic outcomes.

    Beyond disease-focused research, ACADVL antibody supports investigations into exercise physiology, fasting metabolism, and mitochondrial adaptation. By monitoring VLCAD activity, scientists gain insights into how energy metabolism adjusts under varying nutritional and physiological states. This makes the antibody valuable for a wide range of experimental designs.

    ACADVL antibody offered by NSJ Bioreagents provides reliable detection of VLCAD across multiple assay platforms. With proven specificity, it enables researchers to explore the role of fatty acid metabolism in health, disease, and therapeutic interventions.

    UniProt

    P49748

    途径

    ER-Nucleus Signaling, Monocarboxylic Acid Catabolic Process
You are here: